The international art fair will be open until next Sunday. The CAN Art Ibiza contemporary art fair inaugurated its fourth ...

CHATHAM, N.J., June 05, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biotechnology company with marketed products and a ...

MALVERN, Pa., June 26, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for ...

Details on the presentation can be found below. A copy of the Company's poster presentation will be available under the Scientific Presentations tab of the Tonix website at following the conference.

Saol Therapeutics Announces Poster Presentation at the UMDF Mitochondrial Medicine 2025 Conference Provided by PR Newswire Jun 19, 2025, 4:30:00 AM ...

Poster #4 : Pharmacokinetic characterization of buntanetap in plasma of patients with early Alzheimer's and Parkinson's diseases. Presenter: Matthew Peterson, Ph.D., Senior Clinical Scientist.

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) ...

ROSWELL, Ga. and DUBLIN and HAMILTON, Bermuda, June 19, 2025 /PRNewswire/ -- Saol Therapeutics, a privately held, clinical-stage pharmaceutical company, today announced the presentation of key ...

Session Type: E-Poster Poster No.: 145eTiP About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer.